Science policy news weekly roundup: September 23, 2016 ?>

Science policy news weekly roundup: September 23, 2016

The ASBMB’s Public Affairs Department encourages all readers of the Policy Blotter to alert the office about interesting and relevant articles. Please send tips to


What’s new in Blotter news?

Lawmakers introduced three bills, one to the House and two to the Senate, aimed at solving health funding issues stemming from the Zika virus crisis.

New bills aimed to solve the health funding crisis


The U.S. Department of Health and Human Services issued a ruling, that expands existing laws regarding public access to clinical trial information. The expanded law states that results of all Phase 1 clinical trials must be posted on within one year of their completion. After the HHS announcement, the National Institutes of Health announced that all of its agency-funded trials would follow the same rules. These new rules aim to provide more transparent reporting of clinical trial information to the general public. Vice President Joe Biden said he was pleased with the ruling, stating, “These steps will improve the safety, accessibility, and impact of pour clinical research system.”


HHS takes steps to provide more information about clinical trials to the public (NIH)

Feds demand more clinical trial reporting (The Scientist)

Biden announces new steps to improve clinical trials essential to advancing the cancer moonshot (White House)


A study published in the journal Nature explores how income inequality is affecting the biomedical research industry. Their study showed that from 1970s to the early 2000’s wages of U.S. scientists were consistently increasing, however, in the past decade, these wages have been stagnant, or even decreased. This is, in turn, driving many new scientists away from research-centric careers, as opportunities for funding continue to decline.

Science’s 1%: How income inequality is getting worse in research (Nature)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.